[
  {
    "ts": "2025-07-01T14:50:00+00:00",
    "headline": "Biogen Begins Phase III Felzartamab Study for Third Kidney Disease",
    "summary": "BIIB begins phase III dosing of felzartamab primary membranous nephropathy study, targeting a tough-to-treat condition with no approved therapies.",
    "url": "https://finance.yahoo.com/news/biogen-begins-phase-iii-felzartamab-145000688.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "76b1e512-6b6a-39ae-ac52-19600e5fee81",
      "content": {
        "id": "76b1e512-6b6a-39ae-ac52-19600e5fee81",
        "contentType": "STORY",
        "title": "Biogen Begins Phase III Felzartamab Study for Third Kidney Disease",
        "description": "",
        "summary": "BIIB begins phase III dosing of felzartamab primary membranous nephropathy study, targeting a tough-to-treat condition with no approved therapies.",
        "pubDate": "2025-07-01T14:50:00Z",
        "displayTime": "2025-07-01T14:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507",
          "originalWidth": 620,
          "originalHeight": 496,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FrubqPEJ5SQTnAyfM_xUDw--~B/aD00OTY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507.cf.webp",
              "width": 620,
              "height": 496,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CQa3fKpJjXlLKWCIXJxJDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biogen-begins-phase-iii-felzartamab-145000688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-begins-phase-iii-felzartamab-145000688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]